Jason Mallory, PhD
Vice President, Clinical Development
Jason Mallory is the Vice President of Clinical Development at Kriya Therapeutics. Previously, Dr. Mallory was a Clinical Development Leader at Spark Therapeutics, where he focused on liver-targeted AAV gene therapy programs including in Pompe disease, Hemophilia A, and early-stage programs. Prior to Spark, Jason led clinical development activities spanning all phases of drug development for gene therapy programs at GlaxoSmithKline (including on Libmeldy™, a gene therapy for metachromatic leukodystrophy recently approved by the EMA) and Adverum Biotechnologies. Prior to his work in the field of gene therapy, Dr. Mallory spent approximately ten years in clinical development for more prevalent diseases, including for the development and successful global licensure of albiglutide for patients with type 2 diabetes mellitus.
Dr. Mallory received his PhD in Molecular Biology and Genetics and completed his postdoctoral work at the University of Southwestern Medical Center and the Institute of Metabolic Disease at Baylor University Medical Center. Dr. Mallory received his master’s degree in Molecular Biology and Genetics from Baylor University Medical Center, and his undergraduate degree in Biology at Midwestern State University, Wichita Falls.